Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Current Liabilities -----

What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Current Liabilities ratio of NATH BIOGENES (INDIA) is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2013-

How is Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2013 - -

Compare Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹311.4 Cr -6.1% 7.4% 1.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,446.6 Cr -4.2% 0.6% -16.1% Stock Analytics
KAVERI SEED COMPANY ₹4,854.6 Cr -6% 2% -32.2% Stock Analytics
VENKYS (INDIA) ₹2,410.7 Cr 5.9% 17.2% -0.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹983.7 Cr -3.6% -3.9% -25.3% Stock Analytics
INDO US BIOTECH ₹208.5 Cr -7.6% -3% -24.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-6.1%

7.4%

1.5%

SENSEX

-4.3%

-2.6%

-7.6%


You may also like the below Video Courses